These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

158 related items for PubMed ID: 18942761

  • 1. Esophageal ulcer of Crohn's disease: disappearance in 1 week with infliximab.
    Chiba M, Sugawara T, Tsuda H, Abe T, Tokairin T, Kashima Y.
    Inflamm Bowel Dis; 2009 Aug; 15(8):1121-2. PubMed ID: 18942761
    [No Abstract] [Full Text] [Related]

  • 2. Oral ulcerations are associated with the loss of response to infliximab in Crohn's disease.
    Sánchez AR, Rogers RS, Sheridan PJ.
    J Oral Pathol Med; 2005 Jan; 34(1):53-5. PubMed ID: 15610407
    [Abstract] [Full Text] [Related]

  • 3. [Treatment of oesophageal Crohn's disease by infliximab].
    Filippi J, Mambrini P, Arab K, Schneider SM, Hébuterne X.
    Gastroenterol Clin Biol; 2005 Jan; 29(1):84-5. PubMed ID: 15738903
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Distal esophageal involvement in Crohn disease: short treatment with adalimumab.
    Musto D, Martorelli L, Cirillo A, Selvaggi F, Esposito P, Russo MI, Riegler G.
    Endoscopy; 2010 Jan; 42 Suppl 2():E299. PubMed ID: 21113880
    [No Abstract] [Full Text] [Related]

  • 6. Esophageal Crohn's disease treated successfully with adalimumab.
    Kwan LY, Conklin JL, Papadakis KA.
    Inflamm Bowel Dis; 2007 May; 13(5):639-40. PubMed ID: 17221856
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Acute hemorrhagic Crohn's disease controlled with infliximab.
    Meyer MM, Levine EJ.
    Inflamm Bowel Dis; 2009 Oct; 15(10):1456-7. PubMed ID: 19107774
    [No Abstract] [Full Text] [Related]

  • 9. Letter to the editor. Crohn's disease.
    Mughal AA, Chowdhury M, Hawthorne B.
    Int Wound J; 2011 Feb; 8(1):103-4. PubMed ID: 21159128
    [No Abstract] [Full Text] [Related]

  • 10. Cutaneous metastatic Crohn's disease responsive to infliximab.
    Petrolati A, Altavilla N, Cipolla R, Fenderico P, Forlini G, Nasoni S, Rossi Z.
    Am J Gastroenterol; 2009 Apr; 104(4):1058. PubMed ID: 19259072
    [No Abstract] [Full Text] [Related]

  • 11. [Infliximab treatment of severe bleeding complicating Crohn's disease].
    Julián Gómez L, Atienza R, Barrio J, Gil P, Gómez de la Cuesta S, Pinto P, Alcaide N, Caro Patón A.
    Rev Esp Enferm Dig; 2010 Jan; 102(1):57-8. PubMed ID: 20187687
    [No Abstract] [Full Text] [Related]

  • 12. Infiximab for treatment of systemic amyloidosis associated with Crohn's disease.
    Said Y, Debbeche R, Hamzaoui L, Lounissi M, Trabelsi S, Bouzaidi S, Salem M, Abdelmoula L, Najjar T.
    J Crohns Colitis; 2011 Apr; 5(2):171-2. PubMed ID: 21453891
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Treatment of recurrent Crohn's uveitis with infliximab.
    Ally MR, Veerappan GR, Koff JM.
    Am J Gastroenterol; 2008 Aug; 103(8):2150-1. PubMed ID: 18796120
    [No Abstract] [Full Text] [Related]

  • 15. [The use of adalimumab in severe fistulising Crohn's disease].
    Bang UC, Nielsen AM.
    Ugeskr Laeger; 2008 Jun 16; 170(25):2256. PubMed ID: 18565318
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Esophageal ulcer.
    Kepkay DL.
    Can J Gastroenterol; 1998 Jun 16; 12(1):14. PubMed ID: 9544407
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Short-term study of infliximab treatment for Crohn's disease in China.
    Zheng JJ, Zhi P, Wang YM, Zhu F, Gu W, Xing YC, Zhou CL, Shen BW.
    J Dig Dis; 2011 Apr 16; 12(2):105-9. PubMed ID: 21401895
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.